Elevance Health (WBO:ELV) EBIT: €6,578 Mil (TTM As of Mar. 2026)


WBO:ELV Elevance Health Inc WBO:ELV
84 GF Score
Price €344.20
GF Value €445.89
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Elevance Health EBIT?

Elevance Health WBO:ELV +1.35% 84 EBIT is €6,578 Mil as of Mar. 2026. GuruFocus rates WBO:ELV with a GF Score™ of 84/100 and a GF Value™ of €445.89 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Elevance Health's earnings before interest and taxes (EBIT) for the three months ended in Mar. 2026 was €2,302 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2026 was €6,578 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Elevance Health's annualized ROC % for the quarter that ended in Mar. 2026 was 8.89%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Elevance Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 6.91%.


Elevance Health  (WBO:ELV) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Elevance Health's annualized ROC % for the quarter that ended in Mar. 2026 is calculated as:

ROC % (Q: Mar. 2026 )
=NOPAT/Average Invested Capital
=EBIT * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2025 ) + Invested Capital (Q: Mar. 2026 ))/ count )
=9207.06 * ( 1 - 23.61% )/( (76932.0349 + 81348.96825)/ 2 )
=7033.273134/79140.501575
=8.89 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Balance Sheet Cash And Cash Equivalents - 5% * Revenue )
=103755.876 - 20842.724 - ( 8105.314 - 5% * 42483.938 )
=76932.0349

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Balance Sheet Cash And Cash Equivalents - 5% * Revenue )
=108840.355 - 21308.41 - ( 8353.305 - 5% * 43406.565 )
=81348.96825

Note: The EBIT data used here is four times the quarterly (Mar. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

ROC (Joel Greenblatt) % does not apply to banks and insurance companies.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Elevance Health's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Mar. 2026 )
=6577.714/95184.194
=6.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Elevance Health EBIT Related Terms


Elevance Health EBIT Historical Data

* Premium members only.

The historical data trend for Elevance Health's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Elevance Health EBIT Chart

Elevance Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,781.81 7,977.74 8,019.17 8,680.00 6,927.65

Elevance Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,905.43 2,282.81 1,496.96 496.17 2,301.77

WBO:ELV vs CI, CVS, HUM: EBIT Comparison

For the Healthcare Plans subindustry, Elevance Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elevance Health EV-to-EBIT vs Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Elevance Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Elevance Health's EV-to-EBIT falls into.


WBO:ELV
84GF Score
Elevance Health Inc WBO:ELV
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Elevance Health EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €6,578 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of €6,578 Mil mean?
Elevance Health (WBO:ELV) has a EBIT of €6,578 Mil as of Mar. 2026. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Elevance Health.
Is Elevance Health's EBIT too high?
Elevance Health's current EBIT is €6,578 Mil. Overall, Elevance Health has a GF Score™ of 84/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Elevance Health's EBIT compare to CI and CVS?
Elevance Health's EBIT of €6,578 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Healthcare Plans company?
A good EBIT depends on the Healthcare Plans industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Elevance Health. Elevance Health's current EBIT is €6,578 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Elevance Health stock overvalued right now?
Based on GuruFocus' analysis, Elevance Health (WBO:ELV) is currently considered Modestly Undervalued. The stock's GF Value™ is €445.89, compared to a current price of €344.20 — trading 22.8% below its estimated fair value. The current EBIT is €6,578 Mil. Elevance Health's overall GF Score™ is 84/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Elevance Health (WBO:ELV), the current EBIT is €6,578 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Elevance Health (WBO:ELV) Overvalued in 2026?

Based on GuruFocus' analysis, Elevance Health stock appears to be undervalued. The current stock price of €344.20 is trading 22.8% below its estimated GF Value™ of €445.89. GuruFocus considers Elevance Health to be Modestly Undervalued.

Key valuation signals for WBO:ELV:

  • EBIT: €6,578 Mil
  • GF Value™: €445.89 vs. price of €344.20 (22.8% below fair value)
  • GF Score™: 84/100 with 6 warning signs

No single metric tells the full story. See the WBO:ELV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Elevance Health Business Description

Address 220 Virginia Avenue, Indianapolis, IN, USA, 46204
Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.
84GF Score

Get the complete analysis for WBO:ELV

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€344.20
Price
€445.89
GF Value